Marzook, A., Tomas, A. & Jones, B. The interplay of glucagon-like peptide-1 receptor trafficking and signalling in pancreatic beta cells. Front Endocrinol. (Lausanne) 12, 678055 (2021).

Article  PubMed  Google Scholar 

Ibrahim, S. S. et al. The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer. Cancer Metastasis Rev. 43, 141–156 (2024).

MacDonald, P. E. et al. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes 51, S434–442 (2002).

Article  CAS  PubMed  Google Scholar 

Bu, T. et al. Glucagon-like peptide-1: New regulator in lipid metabolism. Diab Metab. J. 48, 354–372 (2024).

Article  Google Scholar 

Zhao, X. et al. GLP-1 receptor agonists: beyond their pancreatic effects. Front Endocrinol. (Lausanne) 12, 721135 (2021).

Article  PubMed  Google Scholar 

Diz-Chaves, Y. et al. Anti-inflammatory effects of GLP-1 receptor activation in the brain in neurodegenerative diseases. Int. J. Mol. Sci. 23, 9583 (2022).

Toft-Nielsen, M. B., Madsbad, S. & Holst, J. J. Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes. J. Clin. Endocrinol. Metab. 86, 3853–3860 (2001).

Article  CAS  PubMed  Google Scholar 

Chen, J. et al. GLP-1 receptor agonist as a modulator of innate immunity. Front Immunol. 13, 997578 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heinla, K. et al. GLP-1 receptor agonists induce growth hormone secretion in healthy volunteers. Diab Ther. 14, 777–786 (2023).

Article  CAS  Google Scholar 

Andreasen, C. R., Andersen, A., Knop, F. K. & Vilsbøll, T. How glucagon-like peptide 1 receptor agonists work. Endocr. Connect 10, R200–r212 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mojsov, S., Weir, G. C. & Habener, J. F. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J. Clin. Invest 79, 616–619 (1987).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo, W. et al. Discovery of ecnoglutide - A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog. Mol. Metab. 75, 101762 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Du, H., Meng, X., Yao, Y. & Xu, J. The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease. Front Endocrinol. (Lausanne) 13, 1033479 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Reich, N. & Hölscher, C. The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review. Front Neurosci. 16, 970925 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Meurot, C. et al. Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity? J. Orthop. Transl. 32, 121–129 (2022).

CAS  Google Scholar 

de Lemos, J. A. et al. Tirzepatide reduces 24-hour ambulatory blood pressure in adults with body mass index ≥27 kg/m(2): SURMOUNT-1 ambulatory blood pressure monitoring substudy. Hypertension 81, e41–e43 (2024).

Article  PubMed  Google Scholar 

Li, Q. X. et al. GLP-1 and underlying beneficial actions in Alzheimer’s disease, hypertension, and NASH. Front Endocrinol. (Lausanne) 12, 721198 (2021).

Article  PubMed  Google Scholar 

Nielsen, R. et al. Effect of liraglutide on myocardial glucose uptake and blood flow in stable chronic heart failure patients: A double-blind, randomized, placebo-controlled LIVE sub-study. J. Nucl. Cardiol. 26, 585–597 (2019).

Article  PubMed  Google Scholar 

Mundil, D., Cameron-Vendrig, A. & Husain, M. GLP-1 receptor agonists: A clinical perspective on cardiovascular effects. Diab Vasc. Dis. Res. 9, 95–108 (2012).

Article  PubMed  Google Scholar 

Lund, P. K., Goodman, R. H., Dee, P. C. & Habener, J. F. Pancreatic preproglucagon cDNA contains two glucagon-related coding sequences arranged in tandem. Proc. Natl. Acad. Sci. USA 79, 345–349 (1982).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bell, G. I., Santerre, R. F. & Mullenbach, G. T. Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 302, 716–718 (1983).

Article  CAS  PubMed  Google Scholar 

Bell, G. I., Sanchez-Pescador, R., Laybourn, P. J. & Najarian, R. C. Exon duplication and divergence in the human preproglucagon gene. Nature 304, 368–371 (1983).

Article  CAS  PubMed  Google Scholar 

Holst, J. J., Orskov, C., Nielsen, O. V. & Schwartz, T. W. Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett. 211, 169–174 (1987).

Article  CAS  PubMed  Google Scholar 

Kreymann, B., Williams, G., Ghatei, M. A. & Bloom, S. R. Glucagon-like peptide-1 7-36: A physiological incretin in man. Lancet 2, 1300–1304 (1987).

Article  CAS  PubMed  Google Scholar 

Eng, J. et al. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J. Biol. Chem. 267, 7402–7405 (1992).

Article  CAS  PubMed  Google Scholar 

Day, J. W. et al. A new glucagon and GLP-1 co-agonist eliminates obesity in rodents. Nat. Chem. Biol. 5, 749–757 (2009).

Article  CAS  PubMed  Google Scholar 

Finan, B. et al. Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans. Sci. Transl. Med. 5, 209ra151 (2013).

Article  PubMed  Google Scholar 

Finan, B. et al. A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents. Nat. Med 21, 27–36 (2015).

Article  CAS  PubMed  Google Scholar 

D’Alessio, D. Is GLP-1 a hormone: Whether and When? J. Diab Investig. 7, 50–55 (2016).

Article  Google Scholar 

Thorens B. Expression cloning of the pancreatic β cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proceedings of the National Academy of Sciences of the United States of America, 89, 8641–8645 (United States, 1992).

Deacon, C. F. & Holst, J. J. Immunoassays for the incretin hormones GIP and GLP-1. Best. Pr. Res Clin. Endocrinol. Metab. 23, 425–432 (2009).

Article  CAS  Google Scholar 

Malik, J. & Roohi, N. GLP-1, a powerful physiological incretin: an update. J. Biol. Regul. Homeost. Agents 32, 1171–1176 (2018).

CAS  PubMed  Google Scholar 

Nadkarni, P., Chepurny, O. G. & Holz, G. G. Regulation of glucose homeostasis by GLP-1. Prog. Mol. Biol. Transl. Sci. 121, 23–65 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Campbell, J. E. & Drucker, D. J. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab. 17, 819–837 (2013).

Article  CAS  PubMed  Google Scholar 

Deacon, C. F. Circulation and degradation of GIP and GLP-1. Horm. Metab. Res 36, 761–765 (2004).

Article  CAS  PubMed  Google Scholar 

Mentlein, R. Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP. Best. Pr. Res Clin. Endocrinol. Metab. 23, 443–452 (2009).

Article